pravastatin has been researched along with Neointima in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Ikuta, S; Iwanaga, Y; Kobuke, K; Miyazaki, S; Ueno, M; Yamaji, K; Yamamoto, H; Yasuda, M | 1 |
| Uemura, S | 1 |
1 trial(s) available for pravastatin and Neointima
| Article | Year |
|---|---|
Difference in statin effects on neointimal coverage after implantation of drug-eluting stents.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Lipids; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Pravastatin; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2014 |
1 other study(ies) available for pravastatin and Neointima
| Article | Year |
|---|---|
Statins and prevention of stent-related late adverse events.
Topics: Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neointima; Percutaneous Coronary Intervention; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2014 |